firstly aimed to estimate serum PON activity in patients with non-insulin dependent diabetes (NIDDM) and its relationship to diabetic complications, including nephropathy, retinopathy, neuropathy and macroangiopathy [18]. Here, PON1 is linked to retinal disorder.